Racial/Ethnic and Poverty Disparities in Human Papillomavirus Vaccination Completion

被引:101
作者
Niccolai, Linda M. [1 ]
Mehta, Niti R.
Hadler, James L.
机构
[1] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT 06520 USA
关键词
CERVICAL-CANCER; UNITED-STATES; YOUNG-WOMEN; ADOLESCENTS; CARE;
D O I
10.1016/j.amepre.2011.06.032
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Two vaccines against human papillomavirus (HPV), a necessary cause of cervical cancer, are currently licensed and recommended for routine administration in the U. S. to girls in a three-dose series. Purpose: This study examined effects of race/ethnicity, poverty, and year on completion of the three-dose HPV vaccine series among those who initiated vaccination. Methods: Data from the 2008-2009 National Immunization Survey-Teen for girls aged 13-17 years who received at least one dose of HPV vaccine (n=7606) were analyzed in 2010-2011 using logistic regression to adjust for covariates including measures of access to care. Results: During this 2-year period, 55% of adolescent girls who initiated vaccination completed the three-dose series. Completion was significantly higher in 2009 (60%) compared to 2008 (48%; p<0.001). After controlling for covariates, adolescents who were black (AOR=0.48, 95% CI=0.40, 0.57) or Hispanic (AOR=0.75, 95% CI=0.64, 0.88) were significantly less likely to complete vaccination than whites. Adolescents living below the federal poverty level were significantly less likely to complete vaccination than adolescents with household incomes >$75,000 (AOR=0.76, 95% CI=0.63, 0.92). There was no significant interaction between race/ethnicity and year (p=0.92). Although poverty was associated with lower completion rates in 2008, this association was not observed in 2009 (p<0.05 for poverty-year interaction). Conclusions: HPV vaccination completion rates increased between 2008 and 2009. However, significant differences by race/ethnicity and poverty were observed, and the racial/ethnic differences persisted. (Am J Prev Med 2011;41(4):428-433) (C) 2011 American Journal of Preventive Medicine
引用
收藏
页码:428 / 433
页数:6
相关论文
共 38 条
[1]  
Advisory Committee on Immunization Practices, VACC CHILDR PROGR VA
[2]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630
[3]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626
[4]  
[Anonymous], 2006, FDA LIC NEW VACC PRE
[5]  
Berry-Caban Cristobal S, 2009, Int J Adolesc Med Health, V21, P567
[6]   Predictors of HPV vaccine acceptability: A theory-informed, systematic review [J].
Brewer, Noel T. ;
Fazekas, Karah I. .
PREVENTIVE MEDICINE, 2007, 45 (2-3) :107-114
[7]  
CDC, VACC CHILDR FREQ ASK
[8]  
CDC, NIS TEEN US GUID 200
[9]  
Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P997
[10]   Correlates for Human Papillomavirus Vaccination of Adolescent Girls and Young Women in a Managed Care Organization [J].
Chao, Chun ;
Velicer, Christine ;
Slezak, Jeff M. ;
Jacobsen, Steven J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (03) :357-367